FibroBiologics, Inc.
FBLG
$0.94
$0.011.14%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.48M | 4.89M | 4.87M | 8.85M | 8.67M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.02M | 1.46M | 373.00K | 1.33M | 642.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 403.00K | -- | -- | -- | 18.00K |
| Total Current Assets | 2.91M | 6.35M | 5.24M | 10.18M | 9.33M |
|
|
|||||
| Total Current Assets | 2.91M | 6.35M | 5.24M | 10.18M | 9.33M |
| Net Property, Plant & Equipment | 2.99M | 3.22M | 3.46M | 3.68M | 2.10M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 48.00K | 48.00K | 48.00K | 48.00K | -- |
| Total Assets | 5.94M | 9.62M | 8.74M | 13.91M | 11.43M |
|
|
|||||
| Total Accounts Payable | 850.00K | 945.00K | 1.07M | 1.80M | 1.42M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 246.00K | -- | 4.57M | 8.07M | 5.84M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 723.00K | 706.00K | 643.00K | 627.00K | 412.00K |
| Total Finance Division Other Current Liabilities | 10.00K | 108.00K | 437.00K | 470.00K | 543.00K |
| Total Other Current Liabilities | 10.00K | 108.00K | 437.00K | 470.00K | 543.00K |
| Total Current Liabilities | 1.83M | 1.76M | 6.72M | 10.96M | 8.21M |
|
|
|||||
| Total Current Liabilities | 1.83M | 1.76M | 6.72M | 10.96M | 8.21M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 246.00K | -- | 4.57M | 8.07M | 5.84M |
| Capital Leases | 1.51M | 1.70M | 1.90M | 2.08M | 865.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 3.34M | 3.46M | 8.62M | 13.05M | 9.08M |
|
|
|||||
| Common Stock & APIC | 61.76M | 60.32M | 51.05M | 46.00M | 42.83M |
| Retained Earnings | -59.16M | -54.16M | -50.92M | -45.14M | -40.48M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 2.60M | 6.16M | 125.00K | 860.00K | 2.35M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.60M | 6.16M | 125.00K | 860.00K | 2.35M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.60M | 6.16M | 125.00K | 860.00K | 2.35M |
|
|
|||||